Viewing Study NCT01314105

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 3:27 AM

Ignite Modification Date: 2026-03-03 @ 5:04 AM

Study NCT ID: NCT01314105

Status: COMPLETED

Last Update Posted: 2025-02-13

First Post: 2011-03-08

Is NOT Gene Therapy: True

Has Adverse Events: True

Brief Title: BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Cancer

Sponsor: Boehringer Ingelheim

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module